HEXACOSANOIC ACID

HEXACOSANOIC ACID is a lipid of Fatty Acyls (FA) class. Hexacosanoic acid is associated with abnormalities such as Adrenoleukodystrophy, Adrenal gland hypofunction and Chronic liver disease NOS. The involved functions are known as peroxisome targeting signal-2 binding activity, Oxidation, Demyelination, Mutation and Biosynthetic Pathways. Hexacosanoic acid often locates in peroxisome, Body tissue, Mitochondria, Membrane and Cytoplasm. The associated genes with HEXACOSANOIC ACID are ABCD1 gene, TRAM1 gene, GPX1 gene, SOD1 gene and SOD2 gene. The related lipids are Fatty Acids, Stearic acid, inositolphosphorylceramide, Very long chain fatty acid and Nonesterified Fatty Acids. The related experimental models are Knock-out.

Cross Reference

Introduction

To understand associated biological information of HEXACOSANOIC ACID, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with HEXACOSANOIC ACID?

HEXACOSANOIC ACID is suspected in Adrenoleukodystrophy, Adrenal gland hypofunction, Chronic liver disease NOS and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with HEXACOSANOIC ACID

MeSH term MeSH ID Detail
Body Weight D001835 333 associated lipids
Liver Diseases D008107 31 associated lipids
Kidney Diseases D007674 29 associated lipids
Leukemia P388 D007941 43 associated lipids
Metabolism, Inborn Errors D008661 46 associated lipids
Adrenoleukodystrophy D000326 29 associated lipids
Diffuse Cerebral Sclerosis of Schilder D002549 8 associated lipids
Arteriosclerosis D001161 86 associated lipids
Metabolic Diseases D008659 12 associated lipids
Adrenocortical Hyperfunction D000308 3 associated lipids
Per page 10 20 | Total 17

PubChem Associated disorders and diseases

What pathways are associated with HEXACOSANOIC ACID

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with HEXACOSANOIC ACID?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with HEXACOSANOIC ACID?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with HEXACOSANOIC ACID?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with HEXACOSANOIC ACID?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with HEXACOSANOIC ACID?

Knock-out

Knock-out are used in the study 'A key role for the peroxisomal ABCD2 transporter in fatty acid homeostasis.' (Fourcade S et al., 2009).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with HEXACOSANOIC ACID

Download all related citations
Per page 10 20 50 100 | Total 136
Authors Title Published Journal PubMed Link
Chen JH et al. [Clinical evaluation of 546 tetracycline-stained teeth treated with Cerinate laminate veneers]. 2003 Zhonghua Kou Qiang Yi Xue Za Zhi pmid:12887798
Cheng J et al. [Studies on the constituents from the stems of Spatholobus suberectus]. 2003 Zhongguo Zhong Yao Za Zhi pmid:15617498
Lii JR et al. [Lipid compounds from Echinacea purpurea]. 2002 Zhongguo Zhong Yao Za Zhi pmid:12774354
Zhang C and Fang YX [Studies on the chemical constituents of Chinese herb Melastoma dodecandrum]. 2003 Zhongguo Zhong Yao Za Zhi pmid:15139128
Qin WJ et al. [Studies on chemical constituents of Heterosmilax yunnanensis]. 2007 Zhong Yao Cai pmid:18074845
Wen J et al. [Studies on the chemical constituent of Ephedra likiangensis]. 1997 Zhong Yao Cai pmid:12572520
Rudenskaia GE et al. [Clinical heterogeneity of X-linked adrenoleukodystrophy ]. 2002 Zh Nevrol Psikhiatr Im S S Korsakova pmid:12497991
Tao ZY et al. [Studies on the chemical constituents of Zanthoxylum dimorphophyllum Hemsl. var spinifolium Rhed. et Wils]. 2001 Yao Xue Xue Bao pmid:12585082
Mdluli K et al. Inhibition of a Mycobacterium tuberculosis beta-ketoacyl ACP synthase by isoniazid. 1998 Science pmid:9616124
Pretorius PJ et al. Biochemical evidence for clinically diagnosed adrenoleucodystrophy in two brothers. 1984 S. Afr. Med. J. pmid:6729621
Sano M et al. [Two adult cases of adrenoleukodystrophy with clinical features of striatonigral degeneration--a probable variant of adrenoleukodystrophy]. 1988 Rinsho Shinkeigaku pmid:3246111
Zarrouk A et al. Accumulation of 24S-hydroxycholesterol in neuronal SK-N-BE cells treated with hexacosanoic acid (C26:0): argument in favor of 24S-hydroxycholesterol as a potential biomarker of neurolipotoxicity. 2015 Rev. Neurol. (Paris) pmid:25577946
Turpin JC et al. [Adult disclosure of a case of familial adrenoleukodystrophy]. 1985 Rev. Neurol. (Paris) pmid:2990005
Ramjit HG et al. A novel coaxial electrospray ionization method for characterizing hexacosanoylceramides by Fourier transform ion cyclotron resonance mass spectrometry. 2005 Rapid Commun. Mass Spectrom. pmid:15838927
Rezanka T and Sigler K Odd-numbered very-long-chain fatty acids from the microbial, animal and plant kingdoms. 2009 May-Jul Prog. Lipid Res. pmid:19336244
Yang P et al. Transcriptome analysis of the Chinese white wax scale Ericerus pela with focus on genes involved in wax biosynthesis. 2012 PLoS ONE pmid:22536429
Khare G et al. Dissecting the role of critical residues and substrate preference of a Fatty Acyl-CoA Synthetase (FadD13) of Mycobacterium tuberculosis. 2009 PLoS ONE pmid:20027301
Lü S et al. Arabidopsis ECERIFERUM9 involvement in cuticle formation and maintenance of plant water status. 2012 Plant Physiol. pmid:22635115
Singh B and Singh S Antimicrobial activity of terpenoids from Trichodesma amplexicaule Roth. 2003 Phytother Res pmid:12916085
Tresch S et al. Inhibition of saturated very-long-chain fatty acid biosynthesis by mefluidide and perfluidone, selective inhibitors of 3-ketoacyl-CoA synthases. 2012 Phytochemistry pmid:22284369
Chen YG et al. Compounds with DNA cleaving activity from Kadsura ananosma. 2006 Pharmazie pmid:17069433
Moser HW et al. The prenatal diagnosis of adrenoleukodystrophy. Demonstration of increased hexacosanoic acid levels in cultured amniocytes and fetal adrenal gland. 1982 Pediatr. Res. pmid:7063272
Van den Branden C et al. Altered adrenocortical response under the influence of experimentally increased serum very long chain fatty acids in rats. 1993 Pathol. Res. Pract. pmid:8397390
Figueiras AN et al. Epicuticular lipids induce aggregation in Chagas disease vectors. 2009 Parasit Vectors pmid:19173716
Petroni A et al. Testosterone metabolites in patients reduce the levels of very long chain fatty acids accumulated in X-adrenoleukodystrophic fibroblasts. 2000 Neurosci. Lett. pmid:10904139
Kyllerman M et al. Central nervous system malformations and white matter changes in pseudo-neonatal adrenoleukodystrophy. 1990 Neuropediatrics pmid:2290480
Tanaka K et al. Electronmicroscopic study on biopsied rectal mucosa in adrenoleukodystrophy. 1987 Neurology pmid:3587618
Rizzo WB et al. Dietary erucic acid therapy for X-linked adrenoleukodystrophy. 1989 Neurology pmid:2682348
Rizzo WB et al. Adrenoleukodystrophy: oleic acid lowers fibroblast saturated C22-26 fatty acids. 1986 Neurology pmid:3951702
Moser HW et al. Adrenoleukodystrophy: increased plasma content of saturated very long chain fatty acids. 1981 Neurology pmid:7202134
Poulos A and Sharp P Plasma and skin fibroblast C26 fatty acids in infantile Refsum's disease. 1984 Neurology pmid:6209596
Miyajima H et al. Increased very long-chain fatty acids in erythrocyte membranes of patients with aceruloplasminemia. 1998 Neurology pmid:9443469
Di Biase A et al. Effects of exogenous hexacosanoic acid on biochemical myelin composition in weaning and post-weaning rats. 1997 Neurochem. Res. pmid:9051669
Di Benedetto R et al. RNAi-mediated silencing of ABCD3 gene expression in rat C6 glial cells: a model system to study PMP70 function. 2008 Neurochem. Int. pmid:18178290
Di Biase A et al. Free radical release in C6 glial cells enriched in hexacosanoic acid: implication for X-linked adrenoleukodystrophy pathogenesis. 2004 Neurochem. Int. pmid:14602084
Xue Q et al. Two new compounds from Semen celosiae and their protective effects against CClâ‚„-induced hepatotoxicity. 2011 Nat. Prod. Res. pmid:20306359
Khan MA et al. Phytochemical investigation of the fruit peels of Citrus reticulata Blanco. 2010 Nat. Prod. Res. pmid:20401792
Engelen M et al. Lovastatin in X-linked adrenoleukodystrophy. 2010 N. Engl. J. Med. pmid:20089986
Sadeghi-Nejad A and Senior B Adrenomyeloneuropathy presenting as Addison's disease in childhood. 1990 N. Engl. J. Med. pmid:2294415
Moser AE et al. The cerebrohepatorenal (Zellweger) syndrome. Increased levels and impaired degradation of very-long-chain fatty acids and their use in prenatal diagnosis. 1984 N. Engl. J. Med. pmid:6709009
Wilkins A et al. Very long chain fatty acid levels in patients diagnosed with multiple sclerosis. 2009 Mult. Scler. pmid:19965514
Rockenbach FJ et al. The effect of bone marrow transplantation on oxidative stress in X-linked adrenoleukodystrophy. 2012 Mol. Genet. Metab. pmid:22525090
Hubbard WC et al. Combined liquid chromatography-tandem mass spectrometry as an analytical method for high throughput screening for X-linked adrenoleukodystrophy and other peroxisomal disorders: preliminary findings. 2006 Sep-Oct Mol. Genet. Metab. pmid:16828324
Pai GS et al. Lovastatin therapy for X-linked adrenoleukodystrophy: clinical and biochemical observations on 12 patients. 2000 Mol. Genet. Metab. pmid:10870849
Deon M et al. Hexacosanoic and docosanoic acids plasma levels in patients with cerebral childhood and asymptomatic X-linked adrenoleukodystrophy: Lorenzo's oil effect. 2008 Metab Brain Dis pmid:18026827
Yanagisawa N et al. Enhanced production of nitric oxide, reactive oxygen species, and pro-inflammatory cytokines in very long chain saturated fatty acid-accumulated macrophages. 2008 Lipids Health Dis pmid:19038055
Wanders RJ et al. Impaired ability of peroxisomes to activate very-long-chain fatty acids in X-linked adrenoleukodystrophy. 1988 Lancet pmid:2899227
Yamamoto Y et al. Chemical Synthesis of a Very Long-Chain Fatty Acid, Hexacosanoic Acid (C26:0), and the Ceramide Containing Hexacosanoic Acid. 2015 J. Nutr. Sci. Vitaminol. pmid:26226958
Kawahara K et al. Hexacosanoate contents in Japanese common foods. 1988 J. Nutr. Sci. Vitaminol. pmid:3244051
Sakai T et al. Very long-chain fatty acids in neutral lipids and glycerophospholipids of adrenoleukodystrophy-cultured skin fibroblasts. 1985 J. Neurol. Sci. pmid:4087027